Smoking is associated with poor therapeutic outcomes in patients with comorbid disease |
Continued smoking increases the risk for developing additional adverse health conditions after diagnosis and/or treatment of a comorbid condition |
Tobacco assessment and cessation support is not well incorporated into clinical care and research for comorbid disease |
People with comorbid conditions appear to have similar or improved motivation to quit. The “teachable moment” may be useful to improve motivation to quit |
Multiple comorbid conditions (psychiatric, cancer, etc.) may occur within a patient who uses tobacco and may be important components of developing individualized care |
Smoking cessation medications may interact with medications used to treat comorbid conditions |
Evidence-based approaches to tobacco cessation (counseling and pharmacotherapy) can be used across comorbid conditions |
All people who use tobacco, with or without a comorbid condition, should receive evidence-based tobacco cessation support |